|
Biological agents
Citations 1-6 of 6 total displayed.
|
Most recent content
(1 Jun 2009):
|
-
The use of infliximab in a patient with idiopathic granulomatous hepatitis
- Sabrina Reenu Kapoor and Neil Snowden
BMJ Case Reports doi: 10.1136/bcr.06.2008.0319
[Summary]
[Full text]
[Request Permissions]
|
Past content
(since Mar 2009):
|
-
Pulmonary actinomycosis complicating infliximab therapy for Crohn disease
- Richard Cohen, William Bowie, Robert Enns, Julia Flint, and Mark Fitzgerald
BMJ Case Reports doi: 10.1136/bcr.11.2008.1262
[Summary]
[Full text]
[Request Permissions]
-
Deterioration of the liver biochemistry due to reactivation of chronic hepatitis B during etanercept treatment for rheumatoid arthritis
- Shu-Chen Kuo, Hui-Ting Lee, Wei-Sheng Chen, Chung-Tei Chou, and Chang-Youh Tsai
BMJ Case Reports doi: 10.1136/bcr.09.2008.0873
[Summary]
[Full text]
[Request Permissions]
-
New onset psoriasis in a patient receiving abatacept for rheumatoid arthritis
- Christina Jost, Josef Hermann, Laila El-Shabrawi Caelen, and Winfried Graninger
BMJ Case Reports doi: 10.1136/bcr.09.2008.0845
[Summary]
[Full text]
[Request Permissions]
-
Inflammatory sciatica due to spinal tophaceous gout
- Dominique Buenzli and Alexander So
BMJ Case Reports doi: 10.1136/bcr.07.2008.0492
[Summary]
[Full text]
[Request Permissions]
-
Lymphoedema: a paradoxical effect of tumour necrosis factor inhibitors – case report and review of literature
- Hajra Ismail Tily and Andras Perl
BMJ Case Reports doi: 10.1136/bcr.07.2008.0520
[Summary]
[Full text]
[Request Permissions]
|
Show Biological agents collections from other journals.
